Crowe tax specialists offer four key takeaways about the Inflation Reduction Act.
The sweeping Inflation Reduction Act of 2022 affects nearly every U.S. industry, and life sciences is certainly no exception. But tax executives in life sciences might not be aware of the potential benefits of the act.
Life sciences companies might be able to tap into these benefits, so it’s important for them to understand the implications – and possible opportunities – of key provisions of the act.
As shared on our recent webinar, “Inflation Reduction Act of 2022: Tax Impact on Life Sciences Companies,” here are four key takeaways for further consideration for tax executives: